BioNTech's long-term outlook helped it shrug off a first-quarter loss and sinking revenue as demand for COVID-19 vaccines ...

Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday ...

A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes 'unintuitive,' revelations of how factors like age, ...

People who got the COVID-19 booster had stronger protection against the virus that causes the disease compared to people who ...

SEPTEMBER 15, 2022 — UTSA Recovery Operations is hosting on-campus COVID-19 vaccine clinics at the Main Campus from 9 a.m. to 4 p.m. on Thursday, September 15 in the Student Union Denman Ballroom (SU ...

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low chemotherapy- ...

A spring Covid booster is being offered to those most at risk from the virus across the UK. Some pharmacies have also started selling the jab privately. Fewer people are entitled to a spring ...

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...

Conference call and webcast scheduled for May 6, 2024, at 8:00 a.m. EDT (2:00 p.m. CEST) MAINZ, Germany, May 6, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today ...

Updated Thu, Apr 25, 2024, 10:53 AM 2 min ... The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their ...